<DOC>
	<DOCNO>NCT00914303</DOCNO>
	<brief_summary>The aim study assess safety , tolerability pharmacokinetics ER tablet AZD3241 follow multiple ascend dos administer healthy male female subject include effect food .</brief_summary>
	<brief_title>Study Evaluate Different Extended Release ( ER ) -Formulations Multiple Ascending Dosing AZD3241</brief_title>
	<detailed_description />
	<criteria>Healthy male female subject 3065 year Body Mass Index ( BMI ) 18 30 kg/m2 weigh least 50 kg 100 kg History clinically significant disease disorder History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Previous history frequent presyncope syncope</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>healthy</keyword>
	<keyword>Healthy volunteer study</keyword>
</DOC>